Podcasts about disclosures

❓ Do I Need a Lawyer for Divorce in Santa Clarita? | Santa Clarita Divorce Thinking about divorce in Santa Clarita and wondering if you really need a lawyer? The answer might surprise you. In this video, we explain when you actually need legal representation—and when you can handle your divorce without hiring attorneys.

Dr. Jessica Ailani talks with Dr. Kathleen Digre about the recognition of symptoms, diagnostic imaging, treatment goals, and the importance of weight loss in managing IIH.  Read the related article in JAMA. Read the related article in Neurology®.  Disclosures can be found at Neurology.org.    

Dr. Andy Southerland talks with Dr. Amrou Sarraj about the importance of understanding anesthesia's impact on patient outcomes, the implications for clinical practice, and future research directions in stroke treatment.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

Dr. Kiran Thakur talks with Dr. Ava Easton about the World Health Organization's technical brief on encephalitis.  Read the related article in The Lancet.  Disclosures can be found at Neurology.org.     

Goldman Sachs' Neema Raphael, the firm's chief data officer and head of data engineering, discusses the role of data in enabling or possibly stalling AI's progress with George Lee, co-head of the Goldman Sachs Global Institute, and Allison Nathan, senior strategist in Goldman Sachs Research. This episode was recorded on September 25, 2025. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. © 2025 Goldman Sachs. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Legal Team talks about advertising disclosures for REALTORS® in Virginia.

Welcome back to Market Moment! In today's episode, Matt, John and Eli explore one of the most common personal finance questions:  "How much should I have in an emergency fund — both before and during retirement?" Together, they unpack the strategy behind building a resilient emergency fund, including:

Mike McGlone, Senior Commodity Strategist at Bloomberg Intelligence, returns to Soar Financially with a sharp macro warning:Gold is powering through its best year since 1979, while the U.S. stock market sits at 2.3 times GDP, its highest level in a century. Mike explains why gold is the ultimate safe haven, why copper's rally is a “spike to sell,” and how deflationary forces from China could slam global markets.#gold #trump #stockmarket ---------------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

To learn more about MindWalk Holdings, go to: https://www.mindwalkai.com/---------------------Alex Krainer breaks down Trump and Netanyahu's Gaza peace plan, U.S. pressure to go to war with Iran, NATO's propaganda against Russia, and why the West's regime-change agenda is collapsing as a multipolar world rises.#Iran #Trump #Israel #Geopolitics---------------------

Dr. Justin Abbatemarco talks with Dr. Daniel Ontaneda about the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis.  Read the related article in The Lancet Neurology.  Disclosures can be found at Neurology.org. 

Gerald Celente, publisher of the Trends Journal, doesn't hold back.He calls U.S. politics a “crime syndicate,” warns that governments use war to mask economic collapse, and explains why gold's surge past $3,700/oz is only the beginning.#gold #geopolitics #AI------------

Colonel Douglas Macgregor joins us to share his unfiltered take on the Middle East.From the impossible coexistence of Israel and Palestine to a new Saudi-Pakistan defense pact backed by China, Macgregor warns that the region is entering a historic turning point. In this interview he explains why he believes:-“Either there's no Palestine or there's no Israel.”-The Islamic world is uniting against Israel.-China and gold-based trade are reshaping power away from the U.S. dollar.#gold #middleeast #geopolitics ---------------------

⚔️ How to Deal with a Contested Divorce in California? | Los Angeles Divorce ⚖️ If you and your spouse can't agree on custody, property, or support, you're facing a contested divorce in California. These cases are complex, costly, and time-consuming—especially in Los Angeles. In this video, we break down what to expect and how to prepare.

Are concerns about the quality and reliability of economic data — as well as its vulnerabilities to political influences — warranted? Former BLS Commissioner Erica Groshen, who served from 2013 to 2017, Laffer Associates' Arthur Laffer, Harvard Business School's Alberto Cavallo, and Goldman Sachs' Joseph Briggs discuss data quality, political influence, and the future of economic indicators with Allison Nathan on Goldman Sachs Exchanges. This episode explores the latest Top of Mind report. This episode was recorded on August 18, 19, 26, and September 11, 2025. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. Goldman Sachs does not endorse any candidate or any political party. © 2025 Goldman Sachs. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Deanna Saylor talks with Dr. Senjuti Saha about colonialism in global health and the importance of pathogen genomics.  Read the related article in The Lancet.  Disclosures can be found at Neurology.org. 

Clem Chambers joins Kai Hoffmann to discuss the Fed's latest rate cut, the U.S. dollar's long-term decline, global manufacturing shifts, and why copper could be the next big trade. We also dive into AI's role in automation, U.S.–China tensions, and the future of universal basic income.#Gold #Silver #copper ------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

The Fed just made its first rate cut since December 2024, and Gregory Mannarino calls it “QE in disguise.” He explains why this 25-point move signals currency destruction, a merger of government and corporations, and the next big wealth transfer.Key takeaways:• Gold could surge to $8,000 with a possible 1:1 Dow/Gold ratio• A looming bond-market spike may trigger a global stock sell-off• Stablecoin tokens and crypto are quietly buying gold as real backing#gold #silver #macro ------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

In the second part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about legal and ethical considerations, the importance of interdisciplinary support, and the emotional impact on clinicians.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

⏱️ How to Finalize a Divorce in San Bernardino County in 6 Weeks? | San Bernardino Divorce

Markets are at record highs as the Fed and Bank of Canada eye possible rate cuts. Senior Portfolio Manager Martin Pelletier joins us to break down what the data means for inflation, housing, oil, and your investments, right before the big Fed decision.#Fed #InterestRates #Inflation ------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

❓ What Happens if Your Spouse Doesn't Respond to Divorce Papers in San Bernardino? | San Bernardino Divorce

Keith McCullough, Founder & CEO of Hedgeye Risk Management, joins Soar Financially just hours before a critical Fed decision to break down the macro forces driving today's markets.From the inverse correlation between gold and the U.S. dollar to stagflation, bond yields, and political pressure on the Fed, Keith explains why inflation is re-accelerating and what investors should do heading into Q4. He also shares insights on China-U.S. trade tensions, AI disruption, and where gold, silver, and stocks could go next.#gold #inflation #ai ------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

While the healthcare sector has lagged behind the broader markets, there are pockets of innovation. Asad Haider, head of the US Healthcare Business Unit in Goldman Sachs Research, and Amit Sinha, head of Life Sciences Investing in Goldman Sachs Asset Management, discuss their outlook for the industry. This episode was recorded on September 8 and 15, 2025. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. Goldman Sachs does not endorse any candidate or any political party. © 2025 Goldman Sachs. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the first part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about the background of the study, the definition and practice of MAID, and the main reasons that lead ALS patients to consider it. Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Are you ready to take the first steps toward Reasonable Assurance (RA) in climate-related disclosures?From understanding what it means for GHG emissions reporting to where companies should begin, this episode breaks it down in a clear, practical way.Join host Catherine Beare in conversation with Rizwan Nasmuddin as they explore how organizations can confidently start their RA journey and why it's becoming essential for credible climate disclosure.Tune in to learn how to move from intent to action.Speakers:Catherine Beare, Regional Director - Business Assurance (UK & Iberia)Ridzwanurahim Bin Nazimuddin, Senior Sustainability Consultant, Intertek AssurisFollow us on- Intertek's Assurance In Action || Twitter || LinkedIn.

Gold at $3,700. The Fed on deck. AI stocks are burning billions.Louis-Vincent Gave returns to reveal why the next decade's power shift may come from a China-India-Russia alliance, not Silicon Valley.#Gold #AI #StockMarket------------Thank you to our #sponsor MONEY METALS. Make sure to pay them a visit: https://bit.ly/BUYGoldSilver------------

Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

What's driving US tech stocks — and what could be ahead for the sector? Peter Callahan, the US Technology, Media and Telecommunications sector specialist within Goldman Sachs Global Banking & Markets, discusses with Chris Hussey on the sidelines of the Goldman Sachs Communacopia + Technology Conference.  Recorded on September 9, 2025.  The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. For additional disclaimers and regulatory disclosures, please visit https://www.goldmansachs.com/insights/podcasts. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. © 2025 Goldman Sachs. All rights reserved Learn more about your ad choices. Visit megaphone.fm/adchoices

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research.  Disclosures can be found at Neurology.org.  

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at Neurology.org. 

Welcome to the "Week in Review," where we delve into the true stories behind this week's headlines. Your host, Tony Brueski, joins hands with a rotating roster of guests, sharing their insights and analysis on a collection of intriguing, perplexing, and often chilling stories that made the news.       This is not your average news recap. With the sharp investigative lens of Tony and his guests, the show uncovers layers beneath the headlines, offering a comprehensive perspective that traditional news can often miss. From high-profile criminal trials to in-depth examinations of ongoing investigations, this podcast takes listeners on a fascinating journey through the world of true crime and current events.       Each episode navigates through multiple stories, illuminating their details with factual reporting, expert commentary, and engaging conversation. Tony and his guests discuss each case's nuances, complexities, and human elements, delivering a multi-dimensional understanding to their audience.  Whether you are a dedicated follower of true crime, or an everyday listener interested in the stories shaping our world, the "Week in Review" brings you the perfect balance of intrigue, information, and intelligent conversation. Expect thoughtful analysis, informed opinions, and thought-provoking discussions beyond the 24-hour news cycle. Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Welcome to the "Week in Review," where we delve into the true stories behind this week's headlines. Your host, Tony Brueski, joins hands with a rotating roster of guests, sharing their insights and analysis on a collection of intriguing, perplexing, and often chilling stories that made the news.       This is not your average news recap. With the sharp investigative lens of Tony and his guests, the show uncovers layers beneath the headlines, offering a comprehensive perspective that traditional news can often miss. From high-profile criminal trials to in-depth examinations of ongoing investigations, this podcast takes listeners on a fascinating journey through the world of true crime and current events.       Each episode navigates through multiple stories, illuminating their details with factual reporting, expert commentary, and engaging conversation. Tony and his guests discuss each case's nuances, complexities, and human elements, delivering a multi-dimensional understanding to their audience.  Whether you are a dedicated follower of true crime, or an everyday listener interested in the stories shaping our world, the "Week in Review" brings you the perfect balance of intrigue, information, and intelligent conversation. Expect thoughtful analysis, informed opinions, and thought-provoking discussions beyond the 24-hour news cycle. Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Adel Nero and Zak “RedPill78” Paine dig into the escalating attacks on RFK Jr., connecting whistleblower reports of CIA sabotage tactics to the broader deep state war against Trump's health agenda. They highlight how chronic illness and poisoned food systems keep Americans weak, while RFK's push for clean living threatens the establishment. The hosts explore how crimes against children may go beyond trafficking—pointing to vaccines, pharmaceuticals, and nutrition policies that cripple generations. The conversation then shifts to the strange Epstein press conference, where survivors' voices were mixed with political theater aimed at tying Trump to Epstein. Adel and Zak argue that Trump's “hoax” framing was a masterstroke, forcing Congress and media to spotlight Epstein like never before, triggering a wave of demands for transparency. Closing thoughts touch on Thomas Massie's curious role in Washington, MTG's motives, and the bigger picture of transhumanist whispers from Xi and Putin. A heavy yet hopeful episode that ties health, corruption, and narrative warfare into the Great Awakening.

What does Friday's disappointing jobs number mean for the Fed – and where are the opportunities for investors today? Rich Privorotsky, head of European One Delta trading in Goldman Sachs Global Banking & Markets, discusses with Chris Hussey.   Recorded on September 5, 2025. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. For additional disclaimers and regulatory disclosures, please visit https://www.goldmansachs.com/insights/podcasts. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. © 2025 Goldman Sachs. All rights reserved Learn more about your ad choices. Visit megaphone.fm/adchoices

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research.  Disclosures can be found at Neurology.org. 

Jon Herold and Burning Bright return with a packed episode diving into Congress's messy Epstein file release, John Solomon's bombshell hints about thumb drives, and new revelations tying Russiagate back to the Clinton Foundation. They break down the role of whistleblowers, Tulsi Gabbard's intelligence shake-up, and how rerun narratives signal bigger disclosures ahead. The hosts also tackle Trump's use of the Alien Enemies Act, his kinetic strike on Venezuelan traffickers, and the broader fight to define presidential wartime authority through the courts. From devolution theory to sovereign “bros” geopolitics, Chicago crime, and Space Command's move to Alabama, this episode weaves lawfare, geopolitics, and narrative warfare into a sharp, funny, and deeply analytical conversation.

In this episode, Former Acting Comptroller of the Currency Brian Brooks and UC Berkeley's Barry Eichengreen discuss the outlook for stablecoins — digital currencies pegged to the value of traditional fiat currencies like the US dollar. Moderated by Goldman Sachs Research's Allison Nathan, the discussion covers the potential implications of a growing stablecoin market existing payment and banking systems, financial markets, and broader financial stability. This episode explores the latest Top of Mind report. This episode was recorded on July 14, 18, and August 7. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. For additional disclaimers and regulatory disclosures, please visit https://www.goldmansachs.com/insights/podcasts. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html. © 2025 Goldman Sachs. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice.  Disclosures can be found at Neurology.org. 

The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky's conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures Podcast links:  The Effect of Epilepsy Surgery on Tonic–Clonic Seizures  Patient Perspectives on Antiseizure Medication Discontinuation  Understanding Acute Symptomatic Seizures    Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge  Article links:  The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation  Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older   Disclosures can be found at Neurology.org.